Bình luận cho Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

Bình luận cho Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study Crypto and Blockchain News 2026-04-18T11:33:54Z https://cryptoinsider.asia/vi/press-release-escmid-sanofis-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study/feed/atom/ WordPress